# OnCo record avasopasem-manganese (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/avasopasem-manganese/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "avasopasem-manganese" ;
  schema:name "Avasopasem manganese"@en ;
  schema:description "Avasopasem is Galera Therapeutics' radioprotector for the severe mouth ulcers of head and neck chemoradiation; its phase 3 trial met its main goal but the FDA asked for another study in 2023."@en ;
  schema:url <https://onco.cc/drugs/avasopasem-manganese/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.eclinm.2025.103539>, <https://clinicaltrials.gov/study/NCT03689712>, <https://clinicaltrials.gov/search?intr=avasopasem> ;
  onco:status "phase-3" ;
  onco:tag "radiation-wave3" ;
  onco:modality "Superoxide dismutase mimetic small molecule" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/> ;
  onco:technologies <https://onco.cc/technologies/radioprotectors/> ;
  onco:companies <https://onco.cc/companies/galera-therapeutics/> ;
  onco:trials <https://onco.cc/trials/roman/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-roman-anderson-eclinicalmedicine-2025/> .